{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:11:57Z","timestamp":1792671117017,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jacc.2020.12.029","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T01:24:23Z","timestamp":1613438663000},"page":"861-871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome"],"prefix":"10.1016","volume":"77","author":[{"given":"Pam R.","family":"Taub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adena","family":"Zadourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron K.","family":"Ormiston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh","family":"Golshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.12.029_bib1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/joim.12895","article-title":"The face of postural tachycardia syndrome\u2014insights from a large cross-sectional online community-based survey","volume":"286","author":"Shaw","year":"2019","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2020.12.029_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-med-041818-011630","article-title":"Postural orthostatic tachycardia syndrome: mechanisms and new therapies","volume":"71","author":"Mar","year":"2020","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jacc.2020.12.029_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s40265-018-0931-5","article-title":"Postural orthostatic tachycardia syndrome: prevalence, pathophysiology, and management","volume":"78","author":"Zadourian","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jacc.2020.12.029_bib4","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/CIRCULATIONAHA.112.144501","article-title":"Postural tachycardia syndrome (POTS)","volume":"127","author":"Raj","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.029_bib5","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2020.12.029_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11910-015-0583-8","article-title":"Postural tachycardia syndrome: beyond orthostatic intolerance","volume":"15","author":"Garland","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jacc.2020.12.029_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10286-013-0212-z","article-title":"What is brain fog? An evaluation of the symptom in postural tachycardia syndrome","volume":"23","author":"Ross","year":"2013","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jacc.2020.12.029_bib8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2018.11.059","article-title":"Postural orthostatic tachycardia syndrome: JACC focus seminar","volume":"73","author":"Bryarly","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.029_bib9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1152\/jappl.1998.84.3.914","article-title":"Effect of standing on neurohumoral responses and plasma volume in healthy subjects","volume":"84","author":"Jacob","year":"1998","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.jacc.2020.12.029_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.hrthm.2010.11.009","article-title":"Abnormalities of angiotensin regulation in postural tachycardia syndrome","volume":"8","author":"Mustafa","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2020.12.029_bib11","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/01.CIR.0000160356.97313.5D","article-title":"Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome","volume":"111","author":"Raj","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.029_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.autneu.2018.04.008","article-title":"Pharmacotherapy for postural tachycardia syndrome","volume":"215","author":"Miller","year":"2018","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jacc.2020.12.029_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.12.029_bib14","doi-asserted-by":"crossref","first-page":"G30","DOI":"10.1093\/eurheartj\/suv058","article-title":"Prognostic and symptomatic benefits with ivabradine: lessons from the SHIFT trial","volume":"17","author":"Komajda","year":"2015","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jacc.2020.12.029_bib15","first-page":"e4448","article-title":"Ivabradine in congestive heart failure: patient selection and perspectives","volume":"11","author":"Sattar","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.jacc.2020.12.029_bib16","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jacc.2017.08.038","article-title":"The clinical use of ivabradine","volume":"70","author":"Koruth","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.029_bib17","first-page":"8542158","article-title":"Cooccurrence of postural orthostatic tachycardia syndrome with two different clinical entities","volume":"2016","author":"Oztunc","year":"2016","journal-title":"Case Rep Pediatr"},{"key":"10.1016\/j.jacc.2020.12.029_bib18","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/europace\/eum235","article-title":"Symptom improvement in postural orthostatic tachycardia syndrome with the sinus node blocker ivabradine","volume":"9","author":"Ewan","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2020.12.029_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1540-8159.2009.02186.x","article-title":"Treatment of inappropriate sinus tachycardia with ivabradine in a patient with postural orthostatic tachycardia syndrome and a dual chamber pacemaker","volume":"32","author":"Khan","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2020.12.029_bib20","first-page":"273","article-title":"Use of ivabradine in postural orthostatic tachycardia syndrome","volume":"3","author":"Dv","year":"2010","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.jacc.2020.12.029_bib21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1540-8167.2011.02078.x","article-title":"Atrioventricular node ablation and pacemaker implantation for recurrent syncope in a patient with postural tachycardia syndrome (POTS)","volume":"22","author":"Nakatani","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2020.12.029_bib22","first-page":"285","article-title":"Successful use of ivabradine in a case of exaggerated autonomic dysfunction","volume":"38","author":"Aliyev","year":"2010","journal-title":"Turk Kardiyol Dern Ars"},{"key":"10.1016\/j.jacc.2020.12.029_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227789","article-title":"Is ivabradine a wonder drug for atypical POTS?","volume":"12","author":"Cheema","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jacc.2020.12.029_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/1874192401004010166","article-title":"Potentially new indication of ivabradine: treatment of a patient with postural orthostatic tachycardia syndrome","volume":"4","author":"Hersi","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.jacc.2020.12.029_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jdiacomp.2015.02.003","article-title":"POTS following traumatic stress: interacting central and intracardiac neural control?","volume":"29","author":"Meyer","year":"2015","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.jacc.2020.12.029_bib26","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10213","article-title":"The effect of ivabradine on the heart rate and sympathovagal balance in postural tachycardia syndrome patients","volume":"6","author":"Barzilai","year":"2015","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.jacc.2020.12.029_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/europace\/euq390","article-title":"Single centre experience of ivabradine in postural orthostatic tachycardia syndrome","volume":"13","author":"McDonald","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2020.12.029_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40256-017-0248-x","article-title":"Ivabradine in postural orthostatic tachycardia syndrome: preliminary experience in children","volume":"18","author":"Delle Donne","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2020.12.029_bib29","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/pace.13182","article-title":"Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience","volume":"40","author":"Ruzieh","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2020.12.029_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autneu.2011.02.004","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"161","author":"Freeman","year":"2011","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jacc.2020.12.029_bib31","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/j.1540-8159.1997.tb04238.x","article-title":"The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing","volume":"20","author":"Grubb","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2020.12.029_bib32","first-page":"276","article-title":"On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications","volume":"109","author":"Wellek","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jacc.2020.12.029_bib34","doi-asserted-by":"crossref","unstructured":"George D, Mallery P. IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp.","DOI":"10.4324\/9780429056765-3"},{"key":"10.1016\/j.jacc.2020.12.029_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40256-017-0252-1","article-title":"Ivabradine for the treatment of postural orthostatic tachycardia syndrome: a systematic review","volume":"18","author":"Gee","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2020.12.029_bib37","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1161\/CIRCULATIONAHA.107.761643","article-title":"Postural tachycardia syndrome","volume":"117","author":"Grubb","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.029_bib38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autneu.2018.03.004","article-title":"Cognitive and psychological issues in postural tachycardia syndrome","volume":"215","author":"Raj","year":"2018","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jacc.2020.12.029_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fphys.2014.00230","article-title":"Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS)","volume":"5","author":"Anderson","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacc.2020.12.029_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/CS20140251","article-title":"Cognitive dysfunction in postural tachycardia syndrome","volume":"128","author":"Arnold","year":"2015","journal-title":"Clin Sci"},{"key":"10.1016\/j.jacc.2020.12.029_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12955-016-0548-x","article-title":"Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome","volume":"14","author":"Moon","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jacc.2020.12.029_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp.2008.144360","article-title":"Psychiatric profile and attention deficits in postural tachycardia syndrome","volume":"80","author":"Raj","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jacc.2020.12.029_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/pgmj.2006.055046","article-title":"Postural orthostatic tachycardia syndrome","volume":"83","author":"Agarwal","year":"2007","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jacc.2020.12.029_bib44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s13311-018-0612-9","article-title":"Efficacy of propranolol, bisoprolol, and pyridostigmine for\u00a0postural tachycardia syndrome: a randomized clinical trial","volume":"15","author":"Moon","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jacc.2020.12.029_bib45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1378\/chest.83.2.436","article-title":"Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients\u00a0with dysautonomia","volume":"83","author":"Gaffney","year":"1983","journal-title":"Chest"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720381316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720381316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:38:39Z","timestamp":1760017119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720381316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0735109720381316"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.12.029","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}